Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Patient Group Says Sri Lanka Stalling On Forcing Down Drug Costs

This article was originally published in PharmAsia News

Executive Summary

A patients group accuses Sri Lanka's health minister of stalling on implementing a new policy to lower the cost of drugs. A spokesman for the health minister in turn blamed a committee of stakeholders considering legislation for delaying the proposed National Medicinal Drugs Policy. The People's Movement for the Rights of Patients in Sri Lanka said that in addition to complaining about that delay and another to a proposed Charter of Patients Rights, it wants movement on a constitutional amendment to make health a fundamental right. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069925

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel